OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.610
+0.010 (0.63%)
At close: Oct 1, 2026, 4:00 PM EDT
1.610
0.00 (0.00%)
After-hours: Oct 1, 2026, 4:15 PM EDT
OS Therapies Stock Forecast
Stock Price Forecast
According to 4 analysts polled by S&P Global, OS Therapies stock has a consensus rating of "Strong Buy" and an average price target of $8.50. The average 1-year stock price forecast is 427.95% higher than the current stock price, while the lowest is $6.00 (+272.67%) and the highest is $13 (+707.45%).
Price Target: $8.50 (+427.95%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for OS Therapies stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Sep '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 2 | 2 | 3 | 3 | 3 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 4 | 3 | 3 | 4 | 4 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Maxim Group | Maxim Group | Buy Maintains $6 | Buy | Maintains | $6 | +272.67% | Sep 25, 2026 |
| Roth MKM | Roth MKM | Buy Reiterates $7 | Buy | Reiterates | $7 | +334.78% | Sep 21, 2026 |
| Lake Street | Lake Street | Buy Reiterates $13 | Buy | Reiterates | $13 | +707.45% | Sep 9, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
26.57M
EPS This Year
-0.70
from -1.03
EPS Next Year
0.35
from -0.70
EPS and Forward PE are based on non-GAAP adjusted numbers.